4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CNS Pharmaceuticals, Inc. (CNSP) operates in the Biotechnology industry and is headquartered in Houston, United States with about 8 employees. Its market capitalization is roughly $7 million. In the fiscal year ended 2025-12-31, CNSP reported $0M in revenue and ($16M) in net income.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($16M) | ($15M) | ($19M) | ($15M) |
| Net Income | ($16M) | ($15M) | ($19M) | ($15M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($5M) | ($6M) | ($3M) | ($2M) | ($4M) |
| Net Income | ($5M) | ($6M) | ($3M) | ($2M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $9M | $9M | $2M | $13M | — |
| Total Liabilities | $4M | $2M | $6M | $5M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CNSP viewer.
About TickerBase · Data methodology & sources